Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617

Treatment of brain metastases of castration-resistant prostate cancer with ²²⁵Ac-PSMA-617

Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1756-1757. doi: 10.1007/s00259-019-04354-z. Epub 2019 May 21.

Mike M Sathekge^{1

2}, Frank Bruchertseifer³, Ismaheel O Lawal^{4

5}, Mariza Vorster^{4

5}, Otto Knoesen⁶, Thabo Lengana^{4

5}, Tebatso G Boshomane^{4

5}, Kgomotso K Mokoala^{4

5}, Alfred Morgenstern^{4

3}

¹ Department of Nuclear Medicine, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa. mike.sathekge@up.ac.za.
² Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria, South Africa. mike.sathekge@up.ac.za.
³ European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.
⁴ Department of Nuclear Medicine, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa.
⁵ Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria, South Africa.
⁶ Nuclear Technology Products (NTP), Pelindaba, South Africa.

No abstract available